References
1. Algorithms of specialized medical care for patients with diabetes. In: I.I. Dedov, M.V. Shestakova, A.Yu. Mayorov (eds). 9th ed. Moscow: UP PRINT, 2019. DOI: https://doi.org/10.14341/DM221S1 (in Russian)
2. Ermolenko V.M., Kozlova T.A., Mikhaylova N.A. the Importance of low-protein diet in slowing the progression of chronic renal failure (literature review). Nefrologiya i dializ [Nephrology and Dialysis]. 2006; 8 (4): 310–9. (in Russian)
3. Handbook of Nutrition and Kidney. 5th ed. In: W.E. Mitch, S. Klahr (eds). Philadelphia: Lippincott Williams and Wilkins, 2005: 330 p.
4. Piccoli G.B., Capizzi I., Vigotti F.N., Leone F., D’Alessandro C., Giuffrida D., et al. Low protein diets in patients with chronic kidney disease: a bridge between mainstream and complementary-alternative medicines? BMC Nephrol. 2016; 17 (1): 76. DOI: https://doi.org/10.1186/s12882-016-0275-x
5. KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease. Am J Kidney Dis. 2007; 49 (2 suppl 2): S12–154. DOI: https://doi.org/10.1053/j.ajkd.2006.12.005
6. American Diabetes Association. 11. Microvascular complications and foot care: standards of medical care in diabetes-2020. Diabetes Care. 2020; 43 (suppl 1): S135–51. DOI: https://doi.org/10.2337/dc20-S011
7. American Diabetes Association. Diabetic nephropathy. Diabetes Care. 2003; 26 (S1): S94–8. DOI: https://doi.org/10.2337/diacare.26.2007.S94
8. Patent No. 2519744 C2 Russian Federation, IPC A61K 36/734; A61K 36/533; A61P 3/10; A61P 3/06. Pharmaceutical composition, agent for the prevention and treatment of metabolic syndrome and diabetic nephropathy and method for its production. Authors: Bezpalko L.V., Rzhepetskaya I.N., Sova E.A., Gorbenko N.I., Ivanova O.V., Zvyagina T.S., Kobylinskaya V.I., Tishchenko R.A., Dobrovol’ny A.A., Shalamay A.S., patent holder: Bezpalko L.V., Shalamay A.S. No. 2011125805/15; declared 06.24.2011; publ. 06.20.2014, Bull. No. 17 (in Russian).
9. Nakaya Y., Minami A., Harada N., et al. Taurine improves insulin sensitivity in the Otsuka Long-Evans Tokushima fatty rat, a model of spontaneous type 2 diabetes. Am J Clin Nutr. 2000; 71 (1): 54–8. DOI: https://doi.org/10.1093/ajcn/71.1.54
10. Ito T., Schaffer S.W., Azuma J. The potential usefulness of taurine on diabetes mellitus and its complications. Amino Acids. 2012; 42 (5): 1529–39. DOI: https://doi.org/10.1007/s00726-011-0883-5
11. Yalcinkaya S., Unlucerci Y., Giris M., et al. Oxidative and nitrosative stress and apoptosis in the liver of rats fed on high methionine diet: protective effect of taurine. Nutrition. 2009; 25 (4): 436–44. DOI: https://doi.org/10.1016/j.nut.2008.09.017
12. Taurine – monograph. Altern Med Rev. 2001; 6 (1): 78–82.
13. Plant sources of phytonutrients for specialized foods with antidiabetic effects. In: V.A. Tutel’yan, T.L. Kiseleva, A.A. Kochetkova (eds). Moscow: BIBLIO-GLOBUS, 2016: 420 p. ISBN 978-5-9909097-5-5. (in Russian)
14. Eddouks M., Bidi A., El Bouhali B., et al. Antidiabetic plants improving insulin sensitivity. J Pharm Pharmacol. 2014; 66 (9): 1197–214. DOI: https://doi.org/10.1111/jphp.12243
15. Den Hartogh D.J., Tsiani E. Antidiabetic properties of curcumin ii: evidence from in vivo studies. Nutrients. 2019; 12 (1). DOI: https://doi.org/10.3390/nu12010058
16. Wickenberg J., Ingemansson S.L., Hlebowicz J. Effects of Curcuma longa (turmeric) on postprandial plasma glucose and insulin in healthy subjects. Nutr J. 2010; 9: 43. DOI: https://doi.org/10.1186/1475-2891-9-43
17. Miranda-Díaz A.G., Pazarín-Villaseñor L., Yanowsky-Escatell F.G., Andrade-Sierra J. Oxidative stress in diabetic nephropathy with early chronic kidney disease. J Diabetes Res. 2016; 2016: 7047238. DOI: https://doi.org/10.1155/2016/7047238
18. Kucher A.G., Kayukov I.G., Grigor’eva N.D., Vasil’ev A.N. Nutrition in different stages of chronic kidney disease. Nefrologiya i dializ [Nephrology and Dialysis]. 2007; 9 (2): 118–35. (in Russian)
19. Smirnov A.V., Beresneva, O.N., Parastaeva M.M., et al. Influence of a low-protein diet (LPD) supplemented by Ketosteril and soy-been isolate on the development of experimental renal failure. Nefrologiya i dializ [Nephrology and Dialysis]. 2006; 8 (4): 344–50. (in Russian)
20. Tutelyan V.A. The chemical composition and calorie content of Russian food. Handbook. Moscow: DeLi Plus, 2012: 284 p. (in Russian)
21. Sharafetdinov Kh.Kh., Shekhetov A.A., Plotnikova O.A. Modern approaches to dietary support for patients with diabetic nephropathy. Voprosy pitaniia [Problems of Nutrition] 2018; 87 (6): 6–15. DOI: https://doi.org/10.24411/0042-8833-2018-10061 (in Russian)
22. Fair D.E., Ogborn M.R., Weiler H.A., et al. Dietary soy protein attenuates renal disease progression after 1 and 3 weeks in Han: SPRD-cy Weanling rats. J Nutr. 2004; 134: 1504–7. DOI: https://doi.org/10.1093/jn/134.6.1504
23. Jing Z., Wei-Jie Y. Effects of soy protein containing isoflavones in patients with chronic kidney disease: a systematic review and meta-analysis. Clin Nutr. 2016; 35 (1): 117–24. DOI: https://doi.org/10.1093/jn/134.6.1504
24. Hansen H.P., Tauber-Lassen E., Jensen B.R., Parving H.H. Effect of dietary protein restriction on prognosis in patients with diabetic nephropathy. Kidney Int. 2002; 62 (1): 220–8. DOI: https://doi.org/10.1046/j.1523-1755.2002.00421.x
25. Nezu U., Kamiyama H. Kondo Y., et al. Effect of low-protein diet on kidney function in diabetic nephropathy: meta-analysis of randomized controlled trials. BMJ Open. 2013; 3 (5): 1–11. DOI: https://doi.org/10.1136/bmjopen-2013-002934
26. Pan Y., Guo L.L., Jin H.M. Low-protein diet for diabetic nephropathy: a meta-analysis of randomized controlled trials. Am J Clin Nutr. 2008; 88 (3): 660–6. DOI: https://doi.org/10.1093/ajcn/88.3.660
27. Zhang J., Liu J., Su J., Tian F. The effects of soy protein on chronic kidney disease: a meta-analysis of randomized controlled trials. Eur J Clin Nutr. 2014; 68 (9): 987–93. DOI: https://doi.org/10.1038/ejcn.2014.112
28. Sharafetdinov Kh.Kh., Plotnikova O.A., Nazarova A.M., et al. Specialized foods with a modified carbohydrate profile in the correction of metabolic disorders in type 2 diabetes. Voprosy pitaniia [Problems of Nutrition] 2017; 86 (6): 56–63. DOI: https://doi.org/10.24411/0042-8833-2017-00006 (in Russian)
29. Tutelyan V.A., Sharafetdinov Kh.Kh., Lapik I.A., Vorobyeva I.S., Sukhanov B.P. Priorities in the development of specialized foods of optimized composition for patients with type 2 diabetes. Voprosy pitaniia [Problems of Nutrition] 2014; 83 (6): 41–51. DOI: https://doi.org/10.24411/0042-8833-2014-00060 (in Russian)
30. Ko G.J., Kalantar-Zadeh K., Goldstein-Fuchs J., Rhee C.M. Dietary approaches in the management of diabetic patients with kidney disease. Nutrients. 2017; 9: 824. DOI: https://doi.org/10.3390/nu9080824
31. Shapiro, H., Theilla M., Attal-Singer J., Singer P. Effects of polyunsaturated fatty acid consumption in diabetic nephropathy. Nat Rev Nephrol. 2011; 7: 110–21. DOI: https://doi.org/10.1038/nrneph.2010.156